The rising prevalence in GLP-1 medications for metabolic conditions has led to a question about application forms : transdermal systems versus capsules. Usually , GLP-1 drugs were only available in oral form, but the development of skin applications provides a alternative option . Transdermal systems might benefit individuals with issues with table